Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer – Italian Sarcoma Group – Australasian Gastrointestinal Trials Group study
Nom du journal : J Clin Oncol
Année : 2005
Volume : 23
Page de départ : 5795
Page de fin : 5804